Evidence map›Paper›PMID 22137413›Full record

SynthesisThe British journal of general practice : the journal of the Royal College of General Practitioners2011

Comparison of methadone and buprenorphine for opiate detoxification (LEEDS trial): a randomised controlled trial.

Nat M J Wright, Laura Sheard, Clive E Adams, Bruno J Rushforth, Wendy Harrison, Nicole Bound, Roger Hart, Charlotte N E Tompkins

Open access · bronzeAbstract readComparative StudyMeta-AnalysisRandomized Controlled Trial
In one paragraph

Synthesis in The British journal of general practice : the journal of the Royal College of General Practitioners, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 9 pooled it
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 9 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Interventions for female drug-using offenders.The Cochrane database of systematic reviews · 2019
    Pooled it
  5. Pooled it
  6. Buprenorphine for managing opioid withdrawal.The Cochrane database of systematic reviews · 2017
    Pooled it
  7. Pharmacological interventions for drug-using offenders.The Cochrane database of systematic reviews · 2015
    Pooled it
  8. Pooled it
  9. Methadone at tapered doses for the management of opioid withdrawal.The Cochrane database of systematic reviews · 2013
    Pooled it
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Buprenorphine versus methadone use in opiate detoxification, are there other factors that should be considered?The British journal of general practice : the journal of the Royal College of General Practitioners · 2012
    Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Nat M J WrightNHS Leeds, based at HMP Leeds, Armley, Leeds. natwright@nhs.net
Laura Sheard
Clive E Adams
Bruno J Rushforth
Wendy Harrison
Nicole Bound
Roger Hart
Charlotte N E Tompkins
University of Leeds · GBHM Prison Service · GBUniversity of Nottingham · GBUniversity of York · GB

Funding

Department of Health
6 · The paper itself

Abstract

backgroundMany opiate users require prescribed medication to help them achieve abstinence, commonly taking the form of a detoxification regime. In UK prisons, drug users are nearly universally treated for their opiate use by primary care clinicians, and once released access GP services where 40% of practices now treat drug users. There is a paucity of evidence evaluating methadone and buprenorphine (the two most commonly prescribed agents in the UK) for opiate detoxification.

aimTo evaluate whether buprenorphine or methadone help to achieve drug abstinence at completion of a reducing regimen for heroin users presenting to UK prison health care for detoxification.

designOpen-label, pragmatic, randomised controlled trial in three prison primary healthcare departments in the north of England.

methodPrisoners (n = 306) using illicit opiates were recruited and given daily sublingual buprenorphine or oral methadone, in the context of routine care, over a standard reduced regimen of not more than 20 days. The primary outcome measure was abstinence from illicit opiates at 8 days post detoxification, as indicated by urine test (self-report/clinical notes where urine sample was not feasible). Secondary outcomes were also recorded.

resultsAbstinence was ascertained for 73.7% at 8 days post detoxification (urine sample = 52.6%, self report = 15.2%, clinical notes = 5.9%). There was no statistically significant difference in the odds of achieving abstinence between methadone and buprenorphine (odds ratio [OR] = 1.69; 95% confidence interval [CI] = 0.81 to 3.51; P = 0.163). Abstinence was associated solely with whether or not the participant was still in prison at that time (15.22 times the odds; 95% CI = 4.19 to 55.28). The strongest association for lasting abstinence was abstinence at an earlier time point.

conclusionThere is equal clinical effectiveness between methadone and buprenorphine in achieving abstinence from opiates at 8 days post detoxification within prison.

Indexed as

Administration, OralAdministration, SublingualAdultAgedBuprenorphineHumansMethadoneMiddle AgedNarcotic AntagonistsOpiate Substitution TreatmentOpioid-Related DisordersPrisonersYoung AdultBuprenorphineMethadoneNarcotic Antagonists

Identifiers

PMID22137413
PMCPMC3223774
OpenAlexW2160272369

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.